RBC Capital Maintains Outperform on Natera, Raises Price Target to $460
9/25/2026
Impact: 75
Healthcare
RBC Capital analyst Dan Leonard has maintained an Outperform rating on Natera (NASDAQ: NTRA) and raised the price target from $350 to $460. This adjustment reflects a positive outlook on the company's performance.
AI summary, not financial advice
Share: